Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Role of Intravenous Magnesium Sulphate and Caffeine in Neonates With Hypoxic Ischemic Encephalopathy (HIE) in a Assiut University Hospital of Children

NCT06694545 is registered in ClinicalTrials.gov with Assiut University as lead sponsor.

NCT NCT06694545
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06694545 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Role of Intravenous Magnesium Sulphate and Caffeine in Neonates With Hypoxic Ischemic Encephalopathy (HIE) in a Assiut University Hospital of Children
Lead sponsor
Assiut University
Phase
Observational
Overall status
Not yet recruiting
Start date
December 1, 2024
Completion date
January 31, 2026
Enrollment
72 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hypoxic ischemic encephalopathy (hie)